TRETTEN®

FDA INDICATION: Tretten® (coagulation factor XIII A-subunit [recombinant]) is indicated for routine prophylaxis of bleeding in patients with congenital factor XIII A-subunit deficiency. Package Insert

CLASS: Recombinant

DISTRIBUTOR: Novo Nordisk

ROUTE OF ADMINISTRATION: Intravenous

ASSAY SIZE (IU): 2000–3125

DILUENT SIZE: 3.2 mL

MIXING DEVICE: Vial adapter

STORAGE: Store refrigerated at 2–8°C (36–46°F) prior to reconstitution. Tretten is stable until the expiration date on the carton and vial label. Do not freeze. Store protected from light.

HALF-LIFE: 5.1 (± 2.6) days

OTHER WEBSITES: mynovosecure.com, tretten-us.com